Action BAFNAPH BAFNA PHARMACEUTICALS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Bafna Pharmaceuticals Limited

Actions

BAFNAPH

INE878I01022

Cours en clôture NSE India S.E.
Autres places de cotation
 00:00:00 04/07/2024 		Varia. 5j. Varia. 1 janv.
91,72 INR +4,99 % Graphique intraday de Bafna Pharmaceuticals Limited +21,53 % -0,30 %
29/05 Bafna Pharmaceuticals Limited approuve la nomination de A. Mohanachandran en tant que secretaire de la societe et responsable de la conformite CI
29/05 Bafna Pharmaceuticals Limited annonce ses résultats pour le quatrième trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Bafna Pharmaceuticals Limited Approves the Appointment of A. Mohanachandran as Company Secretary and Compliance Officer
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Bafna Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Bafna Pharmaceuticals Limited Announces the Inauguration of New Quality Control Laboratory
Bafna Pharmaceuticals Limited Announces Resignation of Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Bafna Pharmaceuticals Resumes Commercial Production of Manufacturing Units in Chennai, India
Bafna Pharmaceuticals Limited Announces Commercial Production
Floods Disrupt Bafna Pharmaceuticals' Manufacturing Plant in Chennai, India
Bafna Pharmaceuticals Limited Announces Suspension of Chennai Production Activity Due to Impact of Michaung Cyclone
Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Bafna Pharmaceuticals Limited Announces Resignation of Kamlesh Kumar Babulal as Non-Executive Independent Director from the Board
Bafna Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Bafna Pharmaceuticals Limited Approves Board Appointment
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Bafna Pharmaceuticals Limited Announces Appointment Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Bafna Pharmaceuticals Limited Announces Resignation of Atul Sachdeva as Director
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BAFNAPH
  4. Actualités Bafna Pharmaceuticals Limited
  5. Autres langues